Selective inhibition of Janus kinase 1 (JAK1) by filgotinib modulates the disease-associated whole blood transcriptional profile of patients with active rheumatoid arthritis - Taylor, P; Downie, B; Zhuo, L; Hawtin, R; Liu, J; Mirza, A (BMJ Publishing Group, 2019)